Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 87520 refers to the detection of the hepatitis C virus (HCV) through nucleic acid testing, specifically utilizing a direct probe technique. Hepatitis C is a viral infection that primarily affects the liver, leading to inflammation and potentially resulting in chronic conditions such as cirrhosis and liver cancer. The detection of HCV's nucleic acid, either DNA or RNA, is crucial for determining the presence of an ongoing or chronic infection in patients. This method is particularly effective in identifying low levels of the virus, which may not be detectable through other means. The direct probe technique involves the use of laboratory-prepared complementary strands of nucleic acid that are designed to bind specifically to the target nucleic acid of the virus. These probes are often labeled with chemical fluorescence, allowing for the formation of stable, double-stranded complexes that can be identified within the sample. This process is essential for accurate diagnosis and management of hepatitis C, as it provides vital information regarding the presence of the virus in the patient's system.
© Copyright 2026 Coding Ahead. All rights reserved.
The procedure associated with CPT® Code 87520 is indicated for the detection of the hepatitis C virus (HCV) in patients who may be experiencing symptoms or conditions related to hepatitis C infection. The following are specific indications for performing this nucleic acid detection:
The procedure for CPT® Code 87520 involves several critical steps to accurately detect the presence of the hepatitis C virus through nucleic acid testing. The following outlines the procedural steps:
After the completion of the nucleic acid detection procedure, the results are analyzed and interpreted by laboratory professionals. The detection of HCV through this method provides critical information regarding the patient's infection status. If the test is positive, further evaluation may be necessary to determine the extent of the infection and appropriate treatment options. Additionally, the results can guide healthcare providers in monitoring the patient's response to treatment and making informed decisions regarding ongoing management of hepatitis C. It is essential for healthcare professionals to communicate the results to the patient and discuss any necessary follow-up actions.
| Short Descr | HEPATITIS C RNA DIR PROBE | Medium Descr | IADNA HEPATITIS C DIRECT PROBE TECHNIQUE | Long Descr | Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, direct probe technique | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 1 | CCS Clinical Classification | 206 - Microscopic examination (bacterial smear, culture, toxicology) |
| 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | GW | Service not related to the hospice patient's terminal condition |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2011-01-01 | Changed | Short description changed. |
| 1998-01-01 | Added | First appearance in code book in 1998. |
Get instant expert-level medical coding assistance.